Literature DB >> 33557836

Hermansky-Pudlak syndrome-2 alters mitochondrial homeostasis in the alveolar epithelium of the lung.

Karina Cuevas-Mora1, Willy Roque2, Hoora Shaghaghi1, Bernadette R Gochuico3, Ivan O Rosas4, Ross Summer5, Freddy Romero6.   

Abstract

BACKGROUND: Mitochondrial dysfunction has emerged as an important player in the pathogenesis of idiopathic pulmonary fibrosis (IPF), a common cause of idiopathic interstitial lung disease in adults. Hermansky-Pudlak syndrome (HPS) is a rare autosomal recessive disorder that causes a similar type of pulmonary fibrosis in younger adults, although the role of mitochondrial dysfunction in this condition is not understood.
METHODS: We performed a detailed characterization of mitochondrial structure and function in lung tissues and alveolar epithelial cells deficient in the adaptor protein complex 3 beta 1 (Ap3b1) subunit, the gene responsible for causing subtype 2 of HPS (HPS-2).
RESULTS: We observed widespread changes in mitochondrial homeostasis in HPS-2 cells, including the acquisition of abnormally shaped mitochondria, with reduced number of cristae, and markedly reduced activity of the electron transport chain and the tricarboxylic acid cycle. We also found that mitochondrial redox imbalance and activity of the mitochondrial unfolded protein response were dysregulated in HPS-2 cells and this associated with various other changes that appeared to be compensatory to mitochondrial dysfunction. This included an increase in glycolytic activity, an upregulation in the expression of mitochondrial biogenesis factors and enhanced activation of the energy-conserving enzyme AMP-activated protein kinase.
CONCLUSION: In summary, our findings indicate that mitochondrial function is dramatically altered in HPS-2 lung tissues, suggesting dysfunction of this organelle might be a driver of HPS lung disease.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33557836      PMCID: PMC7871590          DOI: 10.1186/s12931-021-01640-z

Source DB:  PubMed          Journal:  Respir Res        ISSN: 1465-9921


  40 in total

1.  Activation of the mTORC1/PGC-1 axis promotes mitochondrial biogenesis and induces cellular senescence in the lung epithelium.

Authors:  Ross Summer; Hoora Shaghaghi; DeLeila Schriner; Willy Roque; Dominic Sales; Karina Cuevas-Mora; Vilas Desai; Alok Bhushan; Maria I Ramirez; Freddy Romero
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-03-20       Impact factor: 5.464

2.  Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance.

Authors:  Louise Hecker; Naomi J Logsdon; Deepali Kurundkar; Ashish Kurundkar; Karen Bernard; Thomas Hock; Eric Meldrum; Yan Y Sanders; Victor J Thannickal
Journal:  Sci Transl Med       Date:  2014-04-09       Impact factor: 17.956

3.  Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the beta 3A subunit of the AP-3 adaptor.

Authors:  E C Dell'Angelica; V Shotelersuk; R C Aguilar; W A Gahl; J S Bonifacino
Journal:  Mol Cell       Date:  1999-01       Impact factor: 17.970

Review 4.  Pulmonary Fibrosis in Hermansky-Pudlak Syndrome.

Authors:  Glenn W Vicary; Yeidyly Vergne; Alberto Santiago-Cornier; Lisa R Young; Jesse Roman
Journal:  Ann Am Thorac Soc       Date:  2016-10

5.  Epigenetic mechanisms modulate thyroid transcription factor 1-mediated transcription of the surfactant protein B gene.

Authors:  Yuxia Cao; Tiffany Vo; Guetchyn Millien; Jean-Bosco Tagne; Darrell Kotton; Robert J Mason; Mary C Williams; Maria I Ramirez
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

6.  Gene-edited MLE-15 Cells as a Model for the Hermansky-Pudlak Syndromes.

Authors:  Seunghyi Kook; Aidong Qi; Ping Wang; Shufang Meng; Peter Gulleman; Lisa R Young; Susan H Guttentag
Journal:  Am J Respir Cell Mol Biol       Date:  2018-05       Impact factor: 6.914

7.  Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.

Authors:  Luca Richeldi; Roland M du Bois; Ganesh Raghu; Arata Azuma; Kevin K Brown; Ulrich Costabel; Vincent Cottin; Kevin R Flaherty; David M Hansell; Yoshikazu Inoue; Dong Soon Kim; Martin Kolb; Andrew G Nicholson; Paul W Noble; Moisés Selman; Hiroyuki Taniguchi; Michèle Brun; Florence Le Maulf; Mannaïg Girard; Susanne Stowasser; Rozsa Schlenker-Herceg; Bernd Disse; Harold R Collard
Journal:  N Engl J Med       Date:  2014-05-18       Impact factor: 91.245

8.  BLOC1S5 pathogenic variants cause a new type of Hermansky-Pudlak syndrome.

Authors:  Perrine Pennamen; Linh Le; Angèle Tingaud-Sequeira; Mathieu Fiore; Anne Bauters; Nguyen Van Duong Béatrice; Valentine Coste; Jean-Claude Bordet; Claudio Plaisant; Modibo Diallo; Vincent Michaud; Aurélien Trimouille; Didier Lacombe; Eulalie Lasseaux; Cédric Delevoye; Fanny Morice Picard; Bruno Delobel; Michael S Marks; Benoit Arveiler
Journal:  Genet Med       Date:  2020-06-22       Impact factor: 8.822

9.  Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function.

Authors:  Guoying Yu; Argyris Tzouvelekis; Rong Wang; Jose D Herazo-Maya; Gabriel H Ibarra; Anup Srivastava; Joao Pedro Werneck de Castro; Giuseppe DeIuliis; Farida Ahangari; Tony Woolard; Nachelle Aurelien; Rafael Arrojo E Drigo; Ye Gan; Morven Graham; Xinran Liu; Robert J Homer; Thomas S Scanlan; Praveen Mannam; Patty J Lee; Erica L Herzog; Antonio C Bianco; Naftali Kaminski
Journal:  Nat Med       Date:  2017-12-04       Impact factor: 53.440

10.  Clinical management and outcomes of patients with Hermansky-Pudlak syndrome pulmonary fibrosis evaluated for lung transplantation.

Authors:  Souheil El-Chemaly; Kevin J O'Brien; Steven D Nathan; Gerald L Weinhouse; Hilary J Goldberg; Jean M Connors; Ye Cui; Todd L Astor; Philip C Camp; Ivan O Rosas; Merte Lemma; Vladislav Speransky; Melissa A Merideth; William A Gahl; Bernadette R Gochuico
Journal:  PLoS One       Date:  2018-03-16       Impact factor: 3.240

View more
  2 in total

1.  Modeling of lung phenotype of Hermansky-Pudlak syndrome type I using patient-specific iPSCs.

Authors:  Takahiro Suezawa; Shuhei Kanagaki; Yohei Korogi; Kazuhisa Nakao; Toyohiro Hirai; Koji Murakami; Masatoshi Hagiwara; Shimpei Gotoh
Journal:  Respir Res       Date:  2021-11-04

2.  Role of adaptin protein complexes in intracellular trafficking and their impact on diseases.

Authors:  Juhyun Shin; Arti Nile; Jae-Wook Oh
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.